Skip to main content
Screener/Healthcare/Biotechnology

CLDX — Celldex Therapeutics, Inc.

NASDAQ
$38.21-0.03 (-0.08%)
Mid CapUnder $50Healthcare
$22.10
$45.14
$37.48
$41.62
EPS (TTM)$-4.27
P/E Ratio-8.54
Dividend Yield—
Market Cap$2.61B
Volume314K
Prev Close$38.24
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$15K-$78.7M$-1.180.0%-524566.7%
Q4 '25$75K-$81.4M$-1.23100.0%-108480.0%
Q3 '25$0-$67.0M$-1.01——
Q2 '25$730K-$56.6M$-0.85100.0%-7753.4%
Q1 '25$695K-$53.8M$-0.81100.0%-7740.4%
Q4 '24$1.2M-$47.1M$-0.7130.3%-4007.8%
Q3 '24$3.2M-$42.1M$-0.64100.0%-1320.0%
Q2 '24$2.5M-$35.8M$-0.5468.1%-1434.8%
Get Your Daily Market Recap